Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225009194> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4225009194 endingPage "487" @default.
- W4225009194 startingPage "486" @default.
- W4225009194 abstract "It has been known for many decades that viral respiratory infections are a common cause of asthma exacerbations.1Minor TE Dick EC DeMeo AN Ouellette JJ Cohen M Reed CE. Viruses as precipitants of asthmatic attacks in children.JAMA. 1974; 227: 292-298Crossref PubMed Scopus (251) Google Scholar In fact, more than 80% of asthma exacerbations have been attributed to viral illness in school-aged children, mostly caused by the human rhinovirus (HRV), followed by seasonal coronaviruses, and influenza A and B.2Johnston SL Pattemore PK Sanderson G Smith S Lampe F Josephs L et al.Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.BMJ. 1995; 310: 1225-1229Crossref PubMed Scopus (1660) Google Scholar Increased morbidity in children with asthma was noted during the 2009 H1N1 influenza pandemic.3Kloepfer KM Olenec JP Lee WM Liu G Vrtis RF Roberg KA et al.Increased H1N1 infection rate in children with asthma.Am J Respir Crit Care Med. 2012; 185: 1275-1279Crossref PubMed Scopus (81) Google ScholarIt was, therefore, anticipated that patients with asthma might experience asthma-associated morbidity because of the respiratory virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based on experiences with other respiratory viral infections.1Minor TE Dick EC DeMeo AN Ouellette JJ Cohen M Reed CE. Viruses as precipitants of asthmatic attacks in children.JAMA. 1974; 227: 292-298Crossref PubMed Scopus (251) Google Scholar, 2Johnston SL Pattemore PK Sanderson G Smith S Lampe F Josephs L et al.Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.BMJ. 1995; 310: 1225-1229Crossref PubMed Scopus (1660) Google Scholar, 3Kloepfer KM Olenec JP Lee WM Liu G Vrtis RF Roberg KA et al.Increased H1N1 infection rate in children with asthma.Am J Respir Crit Care Med. 2012; 185: 1275-1279Crossref PubMed Scopus (81) Google Scholar Unexpectedly, children with asthma have not exhibited SARS-CoV-2 at higher rates than children without asthma,4Papadopoulos NK Custovic A Deschildre A Mathioudakis AG Phipatanakul W Wong G et al.Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden.J Allergy Clin Immunol Pract. 2020; 8: 2592-2599Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar nor have they experienced more asthma exacerbations during the current pandemic even in those considered infected with the SARS-CoV-2 virus.5Ruano FJ Alvarez MLS Haroun-Diaz E Vázquez de la Torre M López González P Prieto-Moreno A et al.Impact of the COVID-19 pandemic in children with allergic asthma.J Allergy Clin Immunol Pract. 2020; 8 (e1): 1372-1374Abstract Full Text Full Text PDF Scopus (28) Google Scholar Moreover, several studies have suggested a potential protective effect because of a reduction of the SARS-CoV-2 spike protein receptors on the respiratory epithelial cell membranes in those who are highly allergic or are receiving inhaled corticosteroids.6Lipworth B Chan R RuiWen Kuo C. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: keep calm and carry on.Ann Allergy Asthma Immunol. 2020; 125: 503-504Abstract Full Text Full Text PDF PubMed Scopus (7) Google ScholarAs previously reported,7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar we have found at our medical center a marked improvement in children with asthma, which occurred with school closure in mid-March 2020.8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar This coincided with improved asthma control, decreased asthma exacerbations requiring oral corticosteroids, and fewer emergency department (ED) visits and hospitalizations compared with pre–coronavirus disease 2019 (COVID-19). This occurred even though many of these children had stopped taking their medication, with decreased adherence to both controller and rescue medication.Although the reports of the effects of the COVID-19 pandemic on asthma status have been fairly uniform, explanations for this phenomenon have varied a great deal in the few studies that have addressed this issue.7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar,8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar We have previously reported that, during the pandemic vs the prepandemic period, there was less influenza A and B infection, which coincided with improved asthma status.8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar Aside from the obvious effects of respiratory viral infections on asthma status, exposure to air pollutants per the US Environmental Protection Agency criteria with particulate matter (PM) of less than 2.5 microns (PM2.5), less than 10 microns (PM10), ozone, and nitrogen dioxide have been found to increase asthma exacerbations.9Strickland MJ Darrow LA Klein M Flanders WD Sarnat JA Waller LA et al.Short-term associations between ambient air pollutants and pediatric asthma emergency department visits.Am J Respir Crit Care Med. 2010; 182: 307-316Crossref PubMed Scopus (268) Google Scholar We found that there was a decrease in PM2.5 during the stay-at-home period compared with pre–COVID-19,which coincided with an improvement in asthma status. Of the previous comprehensive epidemiologic reports, the study by Taquechel et al7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar compared fairly well with our study in terms of length of the observation period, the number of key observations of both asthma status (such as ED visits, hospializations, and oral corticosteroid use), and evaluation of factors that can affect thes outcomes and the increased use of virtual telemedicine. In addition, similar to their experience, we found that African American children with asthma had poorer outcomes in terms of ED use during the pandemic. In terms of viral infections, they found that improvement in asthma status coincided with a decrease of HRV, whereas we found this relationship with influenza A and B. In addition, unlike our findings, they did not find any relationship between the air pollutants mentioned above and asthma outcomes, whereas we found that a decrease in PM2.5 coincided with better outcomes.In this issue of the Annals, Stout et al10Stout S Murphy H Pandya A Yeh H-W Portnoy JM The effect of COVID-19 on unscheduled pediatric asthma visits.Annals Allery Asthma Immunol. 2022; 128: 594-595Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar reported on the effect of COVID-19 on asthma visits at their tertiary pediatric hospital. They compared unscheduled and scheduled visits on a 12-monthly basis in 2020 with those in the previous 10 years during the same months from 2010 to 2019. Their main focus was primarily on the effect of 4 variables on asthma and overall visit outcomes. These included the following: (1) positive viral isolates by polymerase chain reaction (HRV, Influenza A and B, and total viral infections); (2) air pollutants (ozone and PM2.5); (3) pollens; and (4) season. The key findings included significantly reduced episodes of hospitalizations, ED visits, and outpatient asthma visits in 2020 vs the previous 10 years, primarily in the spring and fall but not in summer or winter months when all visits were low. These reductions in health care utilization outcomes were sustained when adjusted for air pollutants and pollen counts, whereas a reduced percentage of positive viral isolates correlated with the decrease in asthma visits. It would have been helpful, however, to know the level of air pollutant measured (ie, residential address, zip code region, census blocks, or city level). It was interesting to note that the reduced number of visits during the pandemic months was seen primarily in those less than 5 years of age, whereas we found a marked decrease in morbidity for all age groups 4 to 7, 8 to 11, and 12 years and above during the stay-at-home period. The findings of the study by Stout et al10Stout S Murphy H Pandya A Yeh H-W Portnoy JM The effect of COVID-19 on unscheduled pediatric asthma visits.Annals Allery Asthma Immunol. 2022; 128: 594-595Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar provides increased clarity regarding the importance of reduced respiratory infections on asthma-related health care utilization without the confounding factors of season, pollen, or air pollution in their population. A particular strength of the study design is the 12-month observation period, most during the pandemic, probable stay-at-home management, and the 10-year prepandemic comparison, both of which provide a longer view than other studies we have reviewed.In terms of furthering our understanding of the pandemic effect on asthma, future studies should address economic and racial disparity in health care delivery during the pandemic, prescription practices, use of virtual visits, and adherence patterns.4Papadopoulos NK Custovic A Deschildre A Mathioudakis AG Phipatanakul W Wong G et al.Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden.J Allergy Clin Immunol Pract. 2020; 8: 2592-2599Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar,7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar,8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar Finally, it will be important to clearly establish the direct effect of the SARS-CoV-2 virus on asthma status, both in the short and long term. A recent study suggests that this virus has very little effect on asthma control or exacerbations.5Ruano FJ Alvarez MLS Haroun-Diaz E Vázquez de la Torre M López González P Prieto-Moreno A et al.Impact of the COVID-19 pandemic in children with allergic asthma.J Allergy Clin Immunol Pract. 2020; 8 (e1): 1372-1374Abstract Full Text Full Text PDF Scopus (28) Google Scholar However, this study suffers from a small sample size, inconsistent diagnosis by polymerase chain reaction, and lack of adequate controls. It has been known for many decades that viral respiratory infections are a common cause of asthma exacerbations.1Minor TE Dick EC DeMeo AN Ouellette JJ Cohen M Reed CE. Viruses as precipitants of asthmatic attacks in children.JAMA. 1974; 227: 292-298Crossref PubMed Scopus (251) Google Scholar In fact, more than 80% of asthma exacerbations have been attributed to viral illness in school-aged children, mostly caused by the human rhinovirus (HRV), followed by seasonal coronaviruses, and influenza A and B.2Johnston SL Pattemore PK Sanderson G Smith S Lampe F Josephs L et al.Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.BMJ. 1995; 310: 1225-1229Crossref PubMed Scopus (1660) Google Scholar Increased morbidity in children with asthma was noted during the 2009 H1N1 influenza pandemic.3Kloepfer KM Olenec JP Lee WM Liu G Vrtis RF Roberg KA et al.Increased H1N1 infection rate in children with asthma.Am J Respir Crit Care Med. 2012; 185: 1275-1279Crossref PubMed Scopus (81) Google Scholar It was, therefore, anticipated that patients with asthma might experience asthma-associated morbidity because of the respiratory virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based on experiences with other respiratory viral infections.1Minor TE Dick EC DeMeo AN Ouellette JJ Cohen M Reed CE. Viruses as precipitants of asthmatic attacks in children.JAMA. 1974; 227: 292-298Crossref PubMed Scopus (251) Google Scholar, 2Johnston SL Pattemore PK Sanderson G Smith S Lampe F Josephs L et al.Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.BMJ. 1995; 310: 1225-1229Crossref PubMed Scopus (1660) Google Scholar, 3Kloepfer KM Olenec JP Lee WM Liu G Vrtis RF Roberg KA et al.Increased H1N1 infection rate in children with asthma.Am J Respir Crit Care Med. 2012; 185: 1275-1279Crossref PubMed Scopus (81) Google Scholar Unexpectedly, children with asthma have not exhibited SARS-CoV-2 at higher rates than children without asthma,4Papadopoulos NK Custovic A Deschildre A Mathioudakis AG Phipatanakul W Wong G et al.Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden.J Allergy Clin Immunol Pract. 2020; 8: 2592-2599Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar nor have they experienced more asthma exacerbations during the current pandemic even in those considered infected with the SARS-CoV-2 virus.5Ruano FJ Alvarez MLS Haroun-Diaz E Vázquez de la Torre M López González P Prieto-Moreno A et al.Impact of the COVID-19 pandemic in children with allergic asthma.J Allergy Clin Immunol Pract. 2020; 8 (e1): 1372-1374Abstract Full Text Full Text PDF Scopus (28) Google Scholar Moreover, several studies have suggested a potential protective effect because of a reduction of the SARS-CoV-2 spike protein receptors on the respiratory epithelial cell membranes in those who are highly allergic or are receiving inhaled corticosteroids.6Lipworth B Chan R RuiWen Kuo C. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: keep calm and carry on.Ann Allergy Asthma Immunol. 2020; 125: 503-504Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar As previously reported,7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar we have found at our medical center a marked improvement in children with asthma, which occurred with school closure in mid-March 2020.8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar This coincided with improved asthma control, decreased asthma exacerbations requiring oral corticosteroids, and fewer emergency department (ED) visits and hospitalizations compared with pre–coronavirus disease 2019 (COVID-19). This occurred even though many of these children had stopped taking their medication, with decreased adherence to both controller and rescue medication. Although the reports of the effects of the COVID-19 pandemic on asthma status have been fairly uniform, explanations for this phenomenon have varied a great deal in the few studies that have addressed this issue.7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar,8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar We have previously reported that, during the pandemic vs the prepandemic period, there was less influenza A and B infection, which coincided with improved asthma status.8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar Aside from the obvious effects of respiratory viral infections on asthma status, exposure to air pollutants per the US Environmental Protection Agency criteria with particulate matter (PM) of less than 2.5 microns (PM2.5), less than 10 microns (PM10), ozone, and nitrogen dioxide have been found to increase asthma exacerbations.9Strickland MJ Darrow LA Klein M Flanders WD Sarnat JA Waller LA et al.Short-term associations between ambient air pollutants and pediatric asthma emergency department visits.Am J Respir Crit Care Med. 2010; 182: 307-316Crossref PubMed Scopus (268) Google Scholar We found that there was a decrease in PM2.5 during the stay-at-home period compared with pre–COVID-19,which coincided with an improvement in asthma status. Of the previous comprehensive epidemiologic reports, the study by Taquechel et al7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar compared fairly well with our study in terms of length of the observation period, the number of key observations of both asthma status (such as ED visits, hospializations, and oral corticosteroid use), and evaluation of factors that can affect thes outcomes and the increased use of virtual telemedicine. In addition, similar to their experience, we found that African American children with asthma had poorer outcomes in terms of ED use during the pandemic. In terms of viral infections, they found that improvement in asthma status coincided with a decrease of HRV, whereas we found this relationship with influenza A and B. In addition, unlike our findings, they did not find any relationship between the air pollutants mentioned above and asthma outcomes, whereas we found that a decrease in PM2.5 coincided with better outcomes. In this issue of the Annals, Stout et al10Stout S Murphy H Pandya A Yeh H-W Portnoy JM The effect of COVID-19 on unscheduled pediatric asthma visits.Annals Allery Asthma Immunol. 2022; 128: 594-595Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar reported on the effect of COVID-19 on asthma visits at their tertiary pediatric hospital. They compared unscheduled and scheduled visits on a 12-monthly basis in 2020 with those in the previous 10 years during the same months from 2010 to 2019. Their main focus was primarily on the effect of 4 variables on asthma and overall visit outcomes. These included the following: (1) positive viral isolates by polymerase chain reaction (HRV, Influenza A and B, and total viral infections); (2) air pollutants (ozone and PM2.5); (3) pollens; and (4) season. The key findings included significantly reduced episodes of hospitalizations, ED visits, and outpatient asthma visits in 2020 vs the previous 10 years, primarily in the spring and fall but not in summer or winter months when all visits were low. These reductions in health care utilization outcomes were sustained when adjusted for air pollutants and pollen counts, whereas a reduced percentage of positive viral isolates correlated with the decrease in asthma visits. It would have been helpful, however, to know the level of air pollutant measured (ie, residential address, zip code region, census blocks, or city level). It was interesting to note that the reduced number of visits during the pandemic months was seen primarily in those less than 5 years of age, whereas we found a marked decrease in morbidity for all age groups 4 to 7, 8 to 11, and 12 years and above during the stay-at-home period. The findings of the study by Stout et al10Stout S Murphy H Pandya A Yeh H-W Portnoy JM The effect of COVID-19 on unscheduled pediatric asthma visits.Annals Allery Asthma Immunol. 2022; 128: 594-595Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar provides increased clarity regarding the importance of reduced respiratory infections on asthma-related health care utilization without the confounding factors of season, pollen, or air pollution in their population. A particular strength of the study design is the 12-month observation period, most during the pandemic, probable stay-at-home management, and the 10-year prepandemic comparison, both of which provide a longer view than other studies we have reviewed. In terms of furthering our understanding of the pandemic effect on asthma, future studies should address economic and racial disparity in health care delivery during the pandemic, prescription practices, use of virtual visits, and adherence patterns.4Papadopoulos NK Custovic A Deschildre A Mathioudakis AG Phipatanakul W Wong G et al.Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden.J Allergy Clin Immunol Pract. 2020; 8: 2592-2599Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar,7Taquechel K Diwadkar A Sayed S Dudley JW Grundmeier RW Kenyon CC et al.Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic.J Allergy Clin Immunol Pract. 2020; 8 (e11): 3378-3387Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar,8Guijon OL Morphew T Ehwerhemuepha L Galant SP. Evaluating the impact of coronavirus disease 2019 on asthma morbidity: a comprehensive analysis of potential influencing factors.Ann Allergy Asthma Immunol. 2021; 127: 91-99Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar Finally, it will be important to clearly establish the direct effect of the SARS-CoV-2 virus on asthma status, both in the short and long term. A recent study suggests that this virus has very little effect on asthma control or exacerbations.5Ruano FJ Alvarez MLS Haroun-Diaz E Vázquez de la Torre M López González P Prieto-Moreno A et al.Impact of the COVID-19 pandemic in children with allergic asthma.J Allergy Clin Immunol Pract. 2020; 8 (e1): 1372-1374Abstract Full Text Full Text PDF Scopus (28) Google Scholar However, this study suffers from a small sample size, inconsistent diagnosis by polymerase chain reaction, and lack of adequate controls." @default.
- W4225009194 created "2022-04-29" @default.
- W4225009194 creator A5000133165 @default.
- W4225009194 creator A5037424541 @default.
- W4225009194 creator A5087553931 @default.
- W4225009194 date "2022-05-01" @default.
- W4225009194 modified "2023-09-27" @default.
- W4225009194 title "Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma" @default.
- W4225009194 cites W1964779747 @default.
- W4225009194 cites W2046688069 @default.
- W4225009194 cites W2136703695 @default.
- W4225009194 cites W2166246487 @default.
- W4225009194 cites W3034678323 @default.
- W4225009194 cites W3040251948 @default.
- W4225009194 cites W3045944843 @default.
- W4225009194 cites W3066673556 @default.
- W4225009194 cites W3141852945 @default.
- W4225009194 cites W4210369651 @default.
- W4225009194 doi "https://doi.org/10.1016/j.anai.2022.02.013" @default.
- W4225009194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35489799" @default.
- W4225009194 hasPublicationYear "2022" @default.
- W4225009194 type Work @default.
- W4225009194 citedByCount "0" @default.
- W4225009194 crossrefType "journal-article" @default.
- W4225009194 hasAuthorship W4225009194A5000133165 @default.
- W4225009194 hasAuthorship W4225009194A5037424541 @default.
- W4225009194 hasAuthorship W4225009194A5087553931 @default.
- W4225009194 hasBestOaLocation W42250091941 @default.
- W4225009194 hasConcept C126322002 @default.
- W4225009194 hasConcept C177713679 @default.
- W4225009194 hasConcept C187212893 @default.
- W4225009194 hasConcept C194828623 @default.
- W4225009194 hasConcept C203014093 @default.
- W4225009194 hasConcept C2776042228 @default.
- W4225009194 hasConcept C2779134260 @default.
- W4225009194 hasConcept C3007834351 @default.
- W4225009194 hasConcept C3008058167 @default.
- W4225009194 hasConcept C524204448 @default.
- W4225009194 hasConcept C534529494 @default.
- W4225009194 hasConcept C71924100 @default.
- W4225009194 hasConcept C99454951 @default.
- W4225009194 hasConceptScore W4225009194C126322002 @default.
- W4225009194 hasConceptScore W4225009194C177713679 @default.
- W4225009194 hasConceptScore W4225009194C187212893 @default.
- W4225009194 hasConceptScore W4225009194C194828623 @default.
- W4225009194 hasConceptScore W4225009194C203014093 @default.
- W4225009194 hasConceptScore W4225009194C2776042228 @default.
- W4225009194 hasConceptScore W4225009194C2779134260 @default.
- W4225009194 hasConceptScore W4225009194C3007834351 @default.
- W4225009194 hasConceptScore W4225009194C3008058167 @default.
- W4225009194 hasConceptScore W4225009194C524204448 @default.
- W4225009194 hasConceptScore W4225009194C534529494 @default.
- W4225009194 hasConceptScore W4225009194C71924100 @default.
- W4225009194 hasConceptScore W4225009194C99454951 @default.
- W4225009194 hasIssue "5" @default.
- W4225009194 hasLocation W42250091941 @default.
- W4225009194 hasLocation W42250091942 @default.
- W4225009194 hasLocation W42250091943 @default.
- W4225009194 hasOpenAccess W4225009194 @default.
- W4225009194 hasPrimaryLocation W42250091941 @default.
- W4225009194 hasRelatedWork W3080435357 @default.
- W4225009194 hasRelatedWork W3133975993 @default.
- W4225009194 hasRelatedWork W3162081874 @default.
- W4225009194 hasRelatedWork W4200515529 @default.
- W4225009194 hasRelatedWork W4235375593 @default.
- W4225009194 hasRelatedWork W4280570760 @default.
- W4225009194 hasRelatedWork W4320038740 @default.
- W4225009194 hasRelatedWork W4322724676 @default.
- W4225009194 hasRelatedWork W4322728326 @default.
- W4225009194 hasRelatedWork W3044717675 @default.
- W4225009194 hasVolume "128" @default.
- W4225009194 isParatext "false" @default.
- W4225009194 isRetracted "false" @default.
- W4225009194 workType "article" @default.